Atlas Trials

BOLD MRI and FMISO PET for the Assessment of Hypoxic Tumor Microenvironment in Patients with Oligometastatic Liver Cancer Undergoing Yttirum-90 Selective Internal Radiation Therapy

Clinical trial NCT05250895 · COMPLETED

Trial details

NCT number
NCT05250895
Sponsor
Emory University
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
BCLC Stage a Hepatocellular CarcinomaBCLC Stage B Hepatocellular CarcinomaBCLC Stage C Hepatocellular CarcinomaHepatocellular Carcinoma
Start date
2022-04-28
Primary completion
2025-02-26
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.